To: elmatador who wrote (4477 ) 2/21/2020 12:36:14 PM From: robert b furman Read Replies (1) | Respond to of 13801 Hi el, During the last earnings webcast Dr Steve Schwartz, CEO of Brooks Automation said that his GENEWHIZ division in Life Sciences had been working with their proprietary virus gene sequencing technique. He said they had been working with CDC organizations from 3 continents to identify it. And it's important to note that profile and reputation, the GENEWIZ carries in the scientific community. Immediately, after the outbreak of the Coronavirus, GENEWIZ was contacted by several global international organizations looking for help in the investigation of this epidemic. During the past few weeks, they've been fully engaged in support of numerous organizations including centers for disease control on three different continents. Our teams in the U.S. and China are synthesizing genes that code for the proteins of Coronavirus and synthesizing fragments of the Coronavirus genome, as well as providing numerous other services that will be used in the detection diagnosis and understanding of the outbreak, development of vaccines and production of therapeutic antibodies. Our laboratories and scientists are in high demand and are fully engaged in the service of this important endeavor. We're proud of our contribution and we consider ourselves fortunate to have the trust and support of the teams who're working around the clock to combat this epidemic. Except for the operations team that's been on-site throughout the extended Chinese New Year holidays, the rest of our GENEWIZ China team is away from our labs and will be restricted from returning to work until at least Monday, February 10. BRKS is my second largest holding. They are a excellent management team. Bob